Global Market Size, Forecast, and Trend Highlights Over 2025-2037
ACL Reconstruction Market size was valued at USD 7.7 billion in 2024 and is likely to cross USD 14.7 billion by 2037, expanding at more than 5.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of ACL reconstruction is estimated at USD 8.03 billion.
Cruciate ligaments, also called cruciform ligaments, are present in the anterior of the knee. During the ACL reconstruction surgery, a surgical tissue graft is used to replace the injured cruciate muscles. The growth of the ACL reconstruction market can be attributed to the increasing prevalence of orthopedic injuries, especially sports-related injuries. Moreover, growing prevalence of bone-related diseases, such as osteoporosis, is estimated to boost the market growth. As the participation in sports in increasing, the incidences of sports injury are also surging across the globe. For instance, a report by the American Academy of Pediatrics suggested that in the U.S., more than 3.5 million children under the age of 14 years get sport injuries annually. Furthermore, the growing awareness amongst the people regarding non-invasive surgeries is also anticipated to boost the market growth. Along with this, the increasing healthcare expenditure worldwide, is expected to boost the market growth. As per the statistics by the World Bank, 9.856% of the global GDP was spent for healthcare in 2018.

ACL Reconstruction Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Prevalence of Sport Injuries
- Rising Cases of Osteoarthritis and Osteoporosis
Challenges
- High Cost of Surgeries
- Lack of Health Awareness amongst the Older Population
ACL Reconstruction Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
5.1% |
Base Year Market Size (2024) |
USD 7.7 billion |
Forecast Year Market Size (2037) |
USD 14.7 billion |
Regional Scope |
|
ACL Reconstruction Segmentation
The market is segmented by application into osteoarthritis, rheumatoid arthritis, trauma, and others, out of which, the osteoarthritis segment is anticipated to hold a substantial share in the global ACL reconstruction market over the forecast period on account of growing prevalence of osteoarthritis, especially amongst the older population. Moreover, growing global geriatric population is also estimated to boost the market growth.
Our in-depth analysis of the global ACL reconstruction market includes the following segments
By Graft Type |
|
By Application |
|
By End-User
|
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportACL Reconstruction Industry - Regional Synopsis
On the basis of geographical analysis, the global ACL reconstruction market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.Asia Pacific industry is poised to account for largest revenue share by 2037, impelled by increasing cases of osteoporosis and arthritis in the region. According to the data by the International Osteoporosis Foundation, more than about 50% of all osteoporotic hip fractures are projected to occur in Asia by the year 2050. Moreover, almost all Asian countries fall below the FAO/WHO recommendations for calcium intake of between 1000 and 1300 mg/day. In fact, the calcium intake for Malaysia, the Philippines, and India is as low as 500 mg per day.
North America Market Analysis
The ACL reconstruction market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the growing prevalence of sports injuries, combined with the higher incidences of bone-related diseases. As per the data by the Center for Disease Control and Prevention (CDC), 18.8% of women above the age of 50 years had osteoporosis of the femur neck or lumbar spine, while the rate for men was just 4.2%, in 2017-18.

Companies Dominating the ACL Reconstruction Landscape
- Wright Medical Group N.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Arthrex, Inc.
- DJO, LLC
- Smith & Nephew plc
- Stryker Corporation
- Mylan N.V.
- Novartis International AG
- Johnson & Johnson
- GlaxoSmithKline plc
- Merck & Co.
In the News
-
February 11, 2022: Novartis India Limited, a subsidiary of Novartis AG, to enter a collaborative sales and distribution agreement with Dr. Reddy’s Laboratories, to allow distribution of medicines in India.
-
September 22, 2021: DJO LLC announced the launch of the ‘MedShape DynaNail Hybrid Fusion System’, an expansion in MedShape’s adaptive healing technology that offers anatomically friendly design that simplifies insertion during a surgery.
Author Credits: Radhika Pawar
- Report ID: 4021
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT